CMS Demonstration Project Results

Fresenius Health Partners achieves statistically significant improvement in patient survival and hospitalization in the recently completed CMS ESRD Disease Management Demonstration Project*, while also reducing payer costs. ~December 2010

Fresenius Health Partners clearly outperformed its competitors (and other Demonstration Project participants) achieving the following results*:

• A significantly lower percentage of patients in the FMC program were hospitalized for the first time by one year and two years.
• A significantly lower percentage of patients in the FMC program were hospitalized for cardiovascular disease for the first time by one year and two years.
• A significantly larger percentage of patients in the FMC program survived to the one year and two year time points.
• FMC program experienced estimated savings relative to FFS Medicare based on differences in service utilization throughout all three years of the Demonstration evaluation, with the magnitude of the savings appearing to increase over time.
• FMC Oral Nutritional Supplement program was associated with significantly reduced mortality at one year.
• Significantly higher percentage of patients in the FMC program were wait-listed for transplant.
• FMC achieved greater than 95% of the targeted dialysis Clinical Practice Measures for the Demonstration Project.
• High satisfaction was observed among patients who remained in the FMC program.

*The ESRD DM Demonstration Project was a five year demonstration project (2006 to 2010) conducted by the Centers for Medicare and Medicaid Services (CMS) to test the impact of expanded integrated care (disease management) approaches applied to the Medicare ESRD patient population. The first three years of the Demonstration (2006 through 2008) were evaluated under this project. The analyses were independently performed by Arbor Research Collaborative for Health (the CMS Evaluation Contractor) and results were presented by Arbor Research at the American Society of Nephrology Annual Meeting in November 2010.

The Arbor Research Collaborative for Health abstracts regarding the CMS ESRD Demonstration Project can be viewed in the links below. The Fresenius Health Partners program is identified as DMO C.

Abstract 1:	Hospitalization, Survival, and Transplant Outcomes	Abstract 3:	Financial Evaluation
Abstract 2:	Utilization of High Cost Services	Abstract 4:	Disease management (DM) and Patient-Centered Outcomes

Demo Project Evaluation Report